Celyad (Formally Known as Cardio3 BioSciences)

120 articles with Celyad (Formally Known as Cardio3 BioSciences)

• 

  Celyad's High Hopes for a Path Forward in Cancer Immunotherapy with CYAD-211

  9/2/2020

  Celyad Oncology is at the forefront of cutting-edge immunotherapy and is hopeful of providing a new way forward for patients with relapsed/refractory multiple myeloma.
• 

  Clinical Catch-Up: May 31-June 5

  6/8/2020

  As summer begins, we’re seeing a shift away from COVID-19-related news and a stronger output of other clinical trial news. Here’s a look.
• 

  BioSpace Movers & Shakers, June 5

  6/5/2020

  Biopharma and life sciences companies bolster their leadership teams and board with these Movers & Shakers.
• 

  ASCO Highlights: Takeda, Genentech, Johnson & Johnson and More

  6/1/2020

  The American Society of Clinical Oncology 2020 meeting was held virtually this year due to the COVID-19 pandemic. As usual, there were literally hundreds of abstracts, posters and presentations. Here’s a look at some of the highlights.
• 

  BioSpace Movers & Shakers, May 8

  5/8/2020

  Pharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
• 

  BioSpace Movers & Shakers, March 6

  3/6/2020

  Life sciences and pharma companies from across the globe strengthen their leadership teams and board with this week's Movers & Shakers.
• 

  Clinical Catch-Up: January 13-17

  1/20/2020

  There were plenty of clinical trial announcements this week. Here's a look.
• 

  Clinical Catch-Up: November 11-15

  11/18/2019

  It was a busy week for clinical trial announcements. Here’s a look.
• 

  BioSpace Global Roundup, Sept. 12

  9/12/2019

  Companies and organizations from across Europe, Asia and North America share updates on their business and pipelines.

• Be The Match BioTherapies® and Celyad Announce Collaboration to Advance Development of Allogeneic CAR-T Therapies

  9/10/2019

  Alliance will support the clinical progression of Celyad’s non-gene edited allogeneic CAR-T candidates

• 

  Clinical Catch-Up: September 2-8

  9/9/2019

  Last week was a busy week for clinical trial results. Here’s a look at some of the top stories and reporting.
• 

  BioSpace Movers and Shakers: April 5

  4/5/2019

  Pharma, biotech and life science companies strengthen leadership teams, with news from Vertex, Arvinas, Provention, Enterome, and more.
• 

  BioSpace Movers and Shakers: March 15

  3/15/2019

  Biotech and pharma companies make changes to their executive leadership teams, with moves at Sandoz, PAREXEL, FSD, Karuna, Precision Bio, and more.

• Celyad Announces Third Quarter 2017 Business Update

  11/17/2017

  The Company ended the quarter with €40 million in cash.

• Celyad Reports A First Complete Response In A Relapsed Refractory AML Patient In The THINK Trial

  10/3/2017

• Celyad Reports First Half 2017 Financial Results And Operational Progress

  8/29/2017

• Celyad Announces New Agreements With Celdara Medical And Dartmouth College

  8/4/2017

• BioLife Solutions, Inc. Executes Supply Agreement With Celyad For CryoStor Use In Natural Killer Receptor Based T-Cell (NKR-T) Platform Targeting Solid Tumors And Blood Cancers

  7/31/2017

• Celyad Announces Initiation Of The SHRINK Trial

  7/20/2017

• Celyad Publishes Additional Pre-Clinical Data In Support Of THINK Trial

  6/21/2017